Search research articles
Contact Us
Filters
Showing results (161-170 of 182) with videos related to
Page
of 19
Sort By:
Minerva Dietologica E Gastroenterologica
|
January 1, 1981
[Effects of dietetic integration with essential amino acids in uremic patients treated with long-term hemodialysis]
A Costa, C Rovati, P Degetto, et al.
Osteoarthritis and Cartilage
|
August 20, 2013
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis
R Chiusaroli, M Visentini, C Galimberti, et al.
Drug Research
|
July 1, 2015
Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers
S Persiani, F Sala, C Manzotti, et al.
Biopharmaceutics & Drug Disposition
|
April 27, 2004
Interaction of dexloxiglumide, a cholecystokinin type-1 receptor antagonist, with human cytochromes P450
Michael Hall, Stefano Persiani, Yen-Ling Cheung, et al.
Annals of Internal Medicine
|
July 4, 1998
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial
J Y Reginster, L Meurmans, B Zegels, et al.
British Journal of Cancer
|
July 1, 1992
Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats
M J Appel, M Meijers, A Van Garderen-Hoetmer, et al.
The American Journal of Physiology
|
February 1, 1991
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide
W E Schmidt, W Creutzfeldt, A Schleser, et al.
Lancet (London, England)
|
February 24, 2001
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
J Y Reginster, R Deroisy, L C Rovati, et al.
Digestion
|
January 1, 1990
Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man
W E Schmidt, W Creutzfeldt, M Höcker, et al.
Annals of the New York Academy of Sciences
|
March 23, 1994
Effects of dietary fat on postprandial gastrointestinal motility are inhibited by a cholecystokinin type A receptor antagonist
R De Giorgio, V Stanghellini, M Ricci Maccarini, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 182) with videos related to
Sort By:
Page
of 19
Minerva Dietologica E Gastroenterologica
|
January 1, 1981
[Effects of dietetic integration with essential amino acids in uremic patients treated with long-term hemodialysis]
A Costa, C Rovati, P Degetto, et al.
Osteoarthritis and Cartilage
|
August 20, 2013
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis
R Chiusaroli, M Visentini, C Galimberti, et al.
Drug Research
|
July 1, 2015
Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers
S Persiani, F Sala, C Manzotti, et al.
Biopharmaceutics & Drug Disposition
|
April 27, 2004
Interaction of dexloxiglumide, a cholecystokinin type-1 receptor antagonist, with human cytochromes P450
Michael Hall, Stefano Persiani, Yen-Ling Cheung, et al.
Annals of Internal Medicine
|
July 4, 1998
The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial
J Y Reginster, L Meurmans, B Zegels, et al.
British Journal of Cancer
|
July 1, 1992
Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats
M J Appel, M Meijers, A Van Garderen-Hoetmer, et al.
The American Journal of Physiology
|
February 1, 1991
Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide
W E Schmidt, W Creutzfeldt, A Schleser, et al.
Lancet (London, England)
|
February 24, 2001
Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial
J Y Reginster, R Deroisy, L C Rovati, et al.
Digestion
|
January 1, 1990
Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man
W E Schmidt, W Creutzfeldt, M Höcker, et al.
Annals of the New York Academy of Sciences
|
March 23, 1994
Effects of dietary fat on postprandial gastrointestinal motility are inhibited by a cholecystokinin type A receptor antagonist
R De Giorgio, V Stanghellini, M Ricci Maccarini, et al.
Page
of 19